Cited by CrossRef (26)
- . Epigenetic Drug Discovery. .

- Milad Shahsavari, Sedigheh Arbabian, Farzaneh Hosseini, Mohamad Reza Razavi. LncRNAs PVT1, HULC, and HOTTIP: A promising biomarker trio for diffuse large B-cell lymphoma. Gene Reports 2025;39:102182

- Hitomi Kaneko, Taku Kaitsuka, Kazuhito Tomizawa. Artificial induction of circadian rhythm by combining exogenous BMAL1 expression and polycomb repressive complex 2 inhibition in human induced pluripotent stem cells. Cell. Mol. Life Sci. 2023;80

- Jihoon G. Yoon, Seong-Kyun Lim, Hoseok Seo, Seungbok Lee, Jaeso Cho, Soo Yeon Kim, Hyun Yong Koh, Annapurna H. Poduri, Vijayalakshmi Ramakumaran, Pradeep Vasudevan, Martijn J. de Groot, Jung Min Ko, Dohyun Han, Jong-Hee Chae, Chul-Hwan Lee. De novo missense variants in HDAC3 leading to epigenetic machinery dysfunction are associated with a variable neurodevelopmental disorder. The American Journal of Human Genetics 2024;111:1588

- Daniel H. O Donovan, Jessie Hsu, Huayang Liu, Jon A. Read. Epigenetic Drug Discovery. 2024.

- Manuel Felipe Fernandez, Jacob Choi, Jeffrey Sosman. New Approaches to Targeted Therapy in Melanoma. Cancers 2023;15:3224

- Man-Hyuk Han, Dariya Issagulova, Minhee Park. Interplay between epigenome and 3D chromatin structure. BMB Rep 2023;56:633

- Yunyun Guo, Rui Cheng, Yuqing Wang, Maria E. Gonzalez, Hongshan Zhang, Yang Liu, Celina G. Kleer, Lixiang Xue. Regulation of EZH2 protein stability: new mechanisms, roles in tumorigenesis, and roads to the clinic. eBioMedicine 2024;100:104972

- Min-Ji Song, Mikyoung Kim, Jieun Seo, Heon-Woo Kwon, Chang Hoon Yang, Jung-Sik Joo, Yong-Joon Cho, Hyoung-Pyo Kim. Role of histone modification in chromatin-mediated transcriptional repression in protozoan parasite Trichomonas vaginalis. BMB Rep 2025;58:82

- Milad Shirvaliloo, Reza Akhavan‐Sigari. Epigenetic cues regulating airway development in human lung organoids: Polycomb repressive complex 2 and altered chromatin accessibility determine cell fate. The FASEB Journal 2023;37

- Varvara Maksimova, Julia Makus, Valeriia Popova, Anzhelika Prus, Olga Usalka, Ekaterina Trapeznikova, Ekaterina Zhidkova, Gennady Belitsky, Marianna Yakubovskaya, Kirill Kirsanov. Histone Methyltransferases as a New Target for Epigenetic Action of Vorinostat. Biochemistry Moscow 2023;88:968

- Jianjun Gao, Wujiang Shi, Jiangang Wang, Canghai Guan, Qingfu Dong, Jialin Sheng, Xinlei Zou, Zhaoqiang Xu, Yifei Ge, Chengru Yang, Jiehan Li, Haolin Bao, Xiangyu Zhong, Yunfu Cui. Research progress and applications of epigenetic biomarkers in cancer. Front. Pharmacol. 2024;15

- Cinzia Lanzi, Noemi Arrighetti, Sandro Pasquali, Giuliana Cassinelli. Targeting EZH2 in SMARCB1-deficient sarcomas: Advances and opportunities to potentiate the efficacy of EZH2 inhibitors. Biochemical Pharmacology 2023;215:115727

- Elena Pardi, Anello Marcello Poma, Liborio Torregrossa, Laura Pierotti, Simona Borsari, Simone Della Valentina, Claudio Marcocci, Filomena Cetani. Whole-exome Sequencing of Atypical Parathyroid Tumors Detects Novel and Common Genes Linked to Parathyroid Tumorigenesis. 2024;110:48

- Huanxiao Shi, Yi Ding, Pingxin Sun, Zhuman Lv, Chunyan Wang, Haoxin Ma, Junyu Lu, Bing Yu, Wenlin Li, Chao Wang. Chemical approaches targeting the hurdles of hepatocyte transplantation: mechanisms, applications, and advances. Front. Cell Dev. Biol. 2024;12

- Cem Özdemir, Laura R. Purkey, Anthony Sanchez, Kyle M. Miller. PARticular MARks: Histone ADP-ribosylation and the DNA damage response. DNA Repair 2024;140:103711

- Tiana T. Wang, Ashley Hirons, Marcel Doerflinger, Kevin V. Morris, Scott Ledger, Damian F. J. Purcell, Anthony D. Kelleher, Chantelle L. Ahlenstiel. Current State of Therapeutics for HTLV-1. Viruses 2024;16:1616

- Jianghai Chen, Shanshan Tang, Qiuhan Zheng, Jingyuan Li, Hong Jiang, Huanzi Lu, Guiqing Liao, Kan Li, Yujie Liang. The competitive mechanism of EZH1 and EZH2 in promoting oral squamous cell carcinoma. Experimental Cell Research 2024;436:113957

- Sharayu V Jangam, Lauren C Briere, Kristy L Jay, Jonathan C Andrews, Melissa A Walker, Lance H Rodan, Frances A High, Shinya Yamamoto, David A Sweetser, Michael F Wangler, P Geyer. A de novo missense variant in EZH1 associated with developmental delay exhibits functional deficits in Drosophila melanogaster
. 2023;224

- Jee-Eun Choi, Inwha Baek. Interplay between epigenetics and metabolism controls cancer stem cell plasticity. Front. Epigenet. Epigenom. 2024;2

- Youn-Tae Kwak, Alina P. Montalbano, Andrew M. Kelleher, Mariano Colon-Caraballo, W. Lee Kraus, Mala Mahendroo, Carole R. Mendelson. Decline in corepressor CNOT1 in the pregnant myometrium near term impairs progesterone receptor function and increases contractile gene expression. Journal of Biological Chemistry 2024;300:107484

- Tsai‐Der Chuang, Nhu Ton, Shawn Rysling, Omid Khorram. The in vivo effects of knockdown of long non‐coding RNA XIST on fibroid growth and gene expression. The FASEB Journal 2024;38

- V. P Maksimova, J. V Makus, V. G Popova, A. Yu Prus, O. G Usalka, E. S Trapeznikova, E. M Zhidkova, G. A Belitsky, M. G Yakubovskaya. Histone methyltransferases as a new target for the epigenetic action by vorinostat. Biohimiâ 2023;88:1191

- Xiaojuan Yang, Lu Xu, Li Yang. Recent advances in EZH2-based dual inhibitors in the treatment of cancers. European Journal of Medicinal Chemistry 2023;256:115461

- Watshara Shoombuatong, Ittipat Meewan, Lawankorn Mookdarsanit, Nalini Schaduangrat. Stack-HDAC3i: A high-precision identification of HDAC3 inhibitors by exploiting a stacked ensemble-learning framework. Methods 2024;230:147

- Brajendra K. Tripathi, Nicole H. Hirsh, Xiaolan Qian, Marian E. Durkin, Dunrui Wang, Alex G. Papageorge, Ross Lake, Yvonne A. Evrard, Adam I. Marcus, Suresh S. Ramalingam, Mary Dasso, Karen H. Vousden, James H. Doroshow, Kylie J. Walters, Douglas R. Lowy. The pro-oncogenic noncanonical activity of a RAS•GTP:RanGAP1 complex facilitates nuclear protein export. Nat Cancer 2024;5:1902
